Expansion includes acquisition of novel, high-resolution cryo-electron microscope – with micro electron diffraction (microED) capabilities for solving protein and small molecule structures NovAliX will further develop cryo-EM service offerings for pharmaceutical industry NovAliX, a drug discovery-focused Contract Research Organization (CRO), today announces the expansion of its cryogenic electron microscopy (cryo-EM) technology capability. NovAliX will benefit […]
continue readingNovAliX appoints Dr. Jerome Guillemont as head of drug discovery, alongside two new directors
Founded in 2002 and based in Strasbourg, France, NovAliX is a drug discovery-focused CRO with several unique technologies. It employs 200 researchers, with capabilities combining chemistry and biophysics. NovAliX offers its clients original collaborative models and extensive services within the framework of research programs dedicated to drug discovery. Its ambition is to continue its development […]
continue reading